Kumazawa K, Sobue G, Yamamoto K, Mitsuma T
Fourth Department of Internal Medicine, Aichi Medical University, Japan.
Rinsho Shinkeigaku. 1996 Mar;36(3):423-8.
Calcitonin gene-related peptide (CGRP)-like immunoreactivity has been demonstrated to be present in nerve terminals around the sweat glands. We have previously demonstrated that CGRP modulates the cholinergic sweating activity. The present study was designed to evaluate the locally administrated CGRP on sweating of patients with multiple system atrophy (MSA) and hereditary spinocerebellar ataxia (HSCA) consisting of 10 males and 11 females. Among 9 HSCA, 3 was diagnosed as Machado-Joseph disease by clinical and DNA diagnostic assessment. CGRP and methacholine chloride (MCH) was dissolved in saline solution to specified concentration, and 0.1ml of which was injected intradermally at the center of a forearm test area. The sweat rate was recorded continuously by the capacitance hygrometry in a relatively cool environment in which the spontaneous sweating was absent. CGRP significantly increased the sweat rate when it was administrated with MCH on normal subjects. There was a clear dose-dependent relationship between the dose of CGRP and its enhancement. This enhancement was significantly reduced in patients with MSA as compared with controls. On the other hand, most of HSCA showed no remarkable impairment of CGRP enhancement. These results suggest that peptidergic sweating is extensively affected in patients with MSA but is not in patients with HSCA, which may be the consequence of peptidergic sweating dysfunction in MSA.
降钙素基因相关肽(CGRP)样免疫反应已被证实在汗腺周围的神经末梢中存在。我们之前已经证明CGRP可调节胆碱能性出汗活动。本研究旨在评估局部给予CGRP对多系统萎缩(MSA)和遗传性脊髓小脑共济失调(HSCA)患者出汗的影响,研究对象包括10名男性和11名女性。在9例HSCA患者中,通过临床和DNA诊断评估,有3例被诊断为马查多-约瑟夫病。将CGRP和氯化乙酰甲胆碱(MCH)溶解于盐溶液中配制成特定浓度,取0.1ml在前臂测试区域中心皮内注射。在相对凉爽且无自发汗液分泌的环境中,通过电容式湿度测定法连续记录出汗率。在正常受试者中,当CGRP与MCH联合给药时,可显著提高出汗率。CGRP剂量与其增强作用之间存在明显的剂量依赖性关系。与对照组相比,MSA患者中这种增强作用显著降低。另一方面,大多数HSCA患者的CGRP增强作用没有明显受损。这些结果表明,肽能性出汗在MSA患者中受到广泛影响,而在HSCA患者中则未受影响,这可能是MSA中肽能性出汗功能障碍的结果。